Neurocrine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
NBIX Key Statistics
Stock Snapshot
As of today, Neurocrine(NBIX) shares are valued at $128.21. The company's market cap stands at 12.89B, with a P/E ratio of 27.42.
During the trading session on 2026-04-29, Neurocrine(NBIX) shares reached a daily high of $130.41 and a low of $127.23. At a current price of $128.21, the stock is +0.8% higher than the low and still -1.7% under the high.
Trading activity shows a volume of 721.83K, compared to an average daily volume of 1.14M.
The stock's 52-week range extends from a low of $105.16 to a high of $160.18.
The stock's 52-week range extends from a low of $105.16 to a high of $160.18.
NBIX News
Over the last 7 days, the United States market has remained flat, yet it is up 30% over the past year with earnings forecast to grow by 16% annually. In this en...
Neurocrine (NBIX) announced the first presentation of new two-year data from the Phase 3 CAHtalyst Adult study demonstrating sustained, substantial reductions i...
Analyst ratings
87%
of 30 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.